Santos-Cortez Regie Lyn P, Hu Ying, Sun Fanyue, Benahmed-Miniuk Fairouz, Tao Jian, Kanaujiya Jitendra K, Ademola Samuel, Fadiora Solomon, Odesina Victoria, Nickerson Deborah A, Bamshad Michael J, Olaitan Peter B, Oluwatosin Odunayo M, Leal Suzanne M, Reichenberger Ernst J
Center for Statistical Genetics, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, USA.
Center for Regenerative Medicine and Skeletal Development, Department of Reconstructive Sciences, University of Connecticut Health Center, Farmington, CT, USA.
Eur J Hum Genet. 2017 Oct;25(10):1155-1161. doi: 10.1038/ejhg.2017.121. Epub 2017 Jul 26.
Keloids result from abnormal proliferative scar formation with scar tissue expanding beyond the margin of the original wound and are mostly found in individuals of sub-Saharan African descent. The etiology of keloids has not been resolved but previous studies suggest that keloids are a genetically heterogeneous disorder. Although possible candidate genes have been suggested by genome-wide association studies using common variants, by upregulation in keloids or their involvement in syndromes that include keloid formation, rare coding variants that contribute to susceptibility in non-syndromic keloid formation have not been previously identified. Through analysis of whole-genome data we mapped a locus to chromosome 8p23.3-p21.3 with a statistically significant maximum multipoint LOD score of 4.48. This finding was followed up using exome sequencing and led to the identification of a c.1202T>C (p.(Leu401Pro)) variant in the N-acylsphingosine amidohydrolase (ASAH1) gene that co-segregates with the keloid phenotype in a large Yoruba family. ASAH1 is an acid ceramidase known to be involved in tumor formation by controlling the ratio of ceramide and sphingosine. ASAH1 is also involved in cell proliferation and inflammation, and may affect the development of keloids via multiple mechanisms. Functional studies need to clarify the role of the ASAH1 variant in wound healing.
瘢痕疙瘩是由异常增殖性瘢痕形成导致的,瘢痕组织超出原始伤口边缘,多见于撒哈拉以南非洲裔个体。瘢痕疙瘩的病因尚未明确,但先前的研究表明,瘢痕疙瘩是一种基因异质性疾病。尽管全基因组关联研究利用常见变异提出了可能的候选基因,或者通过瘢痕疙瘩中的上调或它们参与包括瘢痕疙瘩形成的综合征,先前尚未鉴定出导致非综合征性瘢痕疙瘩形成易感性的罕见编码变异。通过对全基因组数据的分析,我们将一个位点定位到8号染色体p23.3 - p21.3,最大多点LOD得分4.48,具有统计学意义。随后使用外显子组测序对这一发现进行跟进,在一个大型约鲁巴家族中发现N - 酰基鞘氨醇酰胺水解酶(ASAH1)基因中的一个c.1202T>C(p.(Leu401Pro))变异与瘢痕疙瘩表型共分离。ASAH1是一种酸性神经酰胺酶,已知通过控制神经酰胺和鞘氨醇的比例参与肿瘤形成。ASAH1还参与细胞增殖和炎症反应,并可能通过多种机制影响瘢痕疙瘩的发展。功能研究需要阐明ASAH1变异在伤口愈合中的作用。